These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12951107)

  • 21. 2D-QSAR in hydroxamic acid derivatives as peptide deformylase inhibitors and antibacterial agents.
    Gupta MK; Mishra P; Prathipati P; Saxena AK
    Bioorg Med Chem; 2002 Dec; 10(12):3713-6. PubMed ID: 12413827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and biological evaluation of flexible and conformationally constrained LpxC inhibitors.
    Löppenberg M; Müller H; Pulina C; Oddo A; Teese M; Jose J; Holl R
    Org Biomol Chem; 2013 Sep; 11(36):6056-70. PubMed ID: 23917427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Solid phase combinatorial synthesis of benzothiazoles and evaluation of topoisomerase II inhibitory activity.
    Choi SJ; Park HJ; Lee SK; Kim SW; Han G; Choo HY
    Bioorg Med Chem; 2006 Feb; 14(4):1229-35. PubMed ID: 16242334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel histone deacetylase inhibitors: design, synthesis, enzyme inhibition, and binding mode study of SAHA-based non-hydroxamates.
    Suzuki T; Nagano Y; Matsuura A; Kohara A; Ninomiya S; Kohda K; Miyata N
    Bioorg Med Chem Lett; 2003 Dec; 13(24):4321-6. PubMed ID: 14643318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chiral pool synthesis and biological evaluation of C-furanosidic and acyclic LpxC inhibitors.
    Müller H; Gabrielli V; Agoglitta O; Holl R
    Eur J Med Chem; 2016 Mar; 110():340-75. PubMed ID: 26866455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Succinimide hydroxamic acids as potent inhibitors of histone deacetylase (HDAC).
    Curtin ML; Garland RB; Heyman HR; Frey RR; Michaelides MR; Li J; Pease LJ; Glaser KB; Marcotte PA; Davidsen SK
    Bioorg Med Chem Lett; 2002 Oct; 12(20):2919-23. PubMed ID: 12270175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of the antibacterial target UDP-(3-O-acyl)-N-acetylglucosamine deacetylase (LpxC): isoxazoline zinc amidase inhibitors bearing diverse metal binding groups.
    Pirrung MC; Tumey LN; Raetz CR; Jackman JE; Snehalatha K; McClerren AL; Fierke CA; Gantt SL; Rusche KM
    J Med Chem; 2002 Sep; 45(19):4359-70. PubMed ID: 12213077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure-activity relationship studies of novel oxygen-incorporated SAHA analogues.
    Kim SA; Jin YL; Kim HS
    Arch Pharm Res; 2009 Jan; 32(1):15-21. PubMed ID: 19183872
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Docking studies of nickel-peptide deformylase (PDF) inhibitors: exploring the new binding pockets.
    Wang Q; Zhang D; Wang J; Cai Z; Xu W
    Biophys Chem; 2006 Jun; 122(1):43-9. PubMed ID: 16545516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design and synthesis of thiazole-5-hydroxamic acids as novel histone deacetylase inhibitors.
    Anandan SK; Ward JS; Brokx RD; Denny T; Bray MR; Patel DV; Xiao XY
    Bioorg Med Chem Lett; 2007 Nov; 17(21):5995-9. PubMed ID: 17827005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design and synthesis of 4'-((5-benzylidene-2,4-dioxothiazolidin-3-yl)methyl)biphenyl-2-carbonitrile analogs as bacterial peptide deformylase inhibitors.
    Khan FA; Patil RH; Shinde DB; Sangshetti JN
    Chem Biol Drug Des; 2016 Dec; 88(6):938-944. PubMed ID: 27401234
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel inhibitors of human histone deacetylases: design, synthesis, enzyme inhibition, and cancer cell growth inhibition of SAHA-based non-hydroxamates.
    Suzuki T; Nagano Y; Kouketsu A; Matsuura A; Maruyama S; Kurotaki M; Nakagawa H; Miyata N
    J Med Chem; 2005 Feb; 48(4):1019-32. PubMed ID: 15715470
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure-activity relationship analysis of the peptide deformylase inhibitor 5-bromo-1H-indole-3-acetohydroxamic acid.
    Petit S; Duroc Y; Larue V; Giglione C; Léon C; Soulama C; Denis A; Dardel F; Meinnel T; Artaud I
    ChemMedChem; 2009 Feb; 4(2):261-75. PubMed ID: 19053131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and Pin1 inhibitory activity of thiazole derivatives.
    Zhao H; Cui G; Jin J; Chen X; Xu B
    Bioorg Med Chem; 2016 Nov; 24(22):5911-5920. PubMed ID: 27692510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel hydroxamic acid-related phosphinates: inhibition of neutral aminopeptidase N (APN).
    Drag M; Grzywa R; Oleksyszyn J
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1516-9. PubMed ID: 17270439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Actinonin, a naturally occurring antibacterial agent, is a potent deformylase inhibitor.
    Chen DZ; Patel DV; Hackbarth CJ; Wang W; Dreyer G; Young DC; Margolis PS; Wu C; Ni ZJ; Trias J; White RJ; Yuan Z
    Biochemistry; 2000 Feb; 39(6):1256-62. PubMed ID: 10684604
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, synthesis and antibacterial activity of 3-methylenepyrrolidine formyl hydroxyamino derivatives as novel peptide deformylase inhibitors.
    Shi W; Ma H; Duan Y; Aubart K; Fang Y; Zonis R; Yang L; Hu W
    Bioorg Med Chem Lett; 2011 Feb; 21(3):1060-3. PubMed ID: 21185180
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and biological evaluation of novel 5-(hydroxamic acid)methyl oxazolidinone derivatives.
    Phillips OA; D'Silva R; Bahta TO; Sharaf LH; Udo EE; Benov L; Eric Walters D
    Eur J Med Chem; 2015 Dec; 106():120-31. PubMed ID: 26536532
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and structure-activity relationships of a series of novel thiazoles as inhibitors of aminoacyl-tRNA synthetases.
    Yu XY; Hill JM; Yu G; Wang W; Kluge AF; Wendler P; Gallant P
    Bioorg Med Chem Lett; 1999 Feb; 9(3):375-80. PubMed ID: 10091687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis, molecular docking and kinetic properties of β-hydroxy-β-phenylpropionyl-hydroxamic acids as Helicobacter pylori urease inhibitors.
    Xiao ZP; Peng ZY; Dong JJ; Deng RC; Wang XD; Ouyang H; Yang P; He J; Wang YF; Zhu M; Peng XC; Peng WX; Zhu HL
    Eur J Med Chem; 2013 Oct; 68():212-21. PubMed ID: 23974021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.